• Epstein—Barr viral infection in children 
To content

Epstein—Barr viral infection in children 

SOVREMENNAYA PEDIATRIYA.2015.4(68):103-110; doi 10.15574/SP.2015.68.103 
 

Epstein—Barr viral infection in children 
 

Volokha A. P.

Shupyk National Medical Academy of Postgraduate Education 
 

Epstein—Barr virus (EBV) — extremely common virus in a population, the causative agent of infectious mononucleosis, symptoms persist lifelong in infected individuals. Unlike other herpesviruses reactivation of EBV does not have significant value in clinical practice, except immunocompromised patients (X-linked lymphoproliferative syndrome, immunosuppression after transplantation), who develops lymphoproliferative disorders. Epstein—Barr virus is associated with the development of malignancy. Primary EBV infection is usually asymptomatic in young children, at an older age it occurs with classical symptoms: fever, sore throat, lymphadenopathy. Recovery complete within a few weeks of onset. The mainstay of treatment EBV-induced infectious mononucleosis is symptomatic therapy. The issue of appointment of antiviral drugs and corticosteroids in the treatment of primary EBV-infection is debatаble and not recommended in general. 
 

Key words: Epstein—Barr virus, infectious mononucleosis, children. 
 

REFERENCES

1. Candy B, Hotopf M. 2006. Steroids for symptom control in infectious mononucleosis. Cochrane Database Syst Rev. 3: CD004402. http://dx.doi.org/10.1002/14651858.cd004402.pub2

2. Carbone A, Gloghini A, Dotti G. 2008. EBV-Associated lymphoproliferative disorders: classification and treatment. The Oncologist. 13: 577—585. http://dx.doi.org/10.1634/theoncologist.2008-0036; PMid:18515742

3. Centers for Disease Control and Prevention, National Center for Infectious Diseases. Epstein—Barr virus and infectious mononucleosis. Updated May 16, 2006. http://www.cdc.gov/ncidod/diseases/ebv.htm. Accessed December 20, 2011.

4. Ebell MH. 2004. Epstein—Barr virus infectious mononucleosis. Am Fam Physician. 70(7): 1279—1287. PMid:15508538

5. Hellwig T, Jude K, Meyer B. 2013. Management options for infectious mononucleosis. US Pharmacist. 38(5): 38—41.

6. Macsween KF, Higgins CD, McAulay KA et al. 2010. Infectious mononucleosis in university students in the United Kingdom: evaluation of the clinical features and consequences of the disease. Clinical Infectious Diseases. 50: 699—706. http://dx.doi.org/10.1086/650456; PMid:20121570

7. Johanssen EC, Kaye KM. 2010. Epstein—Barr virus (Infectious mononucleosis, Epstein—Barr virus_associated malignant diseases, and other diseases). Douglas and Bennett's Principles and Practice of Infectious Diseases. Mandell GL, Bennett JE, Dolin R Mandell. 7th Ed. Churchill Livingstone Elsevier: 1989—2010.

8. Junker AK. 2005. Epstein—Barr virus. Pediatrics in review. 26(3): 79—85. http://dx.doi.org/10.1542/pir.26-3-79; PMid:15743754

9. Katz BZ. 2008. Epstein—Barr virus (mononucleosis and lymphoproliferative disorders). Principles and Practice of Pediatric Infectious Diseases. Long SS, Pickering LK, Prober CG. Churchill Livingstone: 1036—1044.

10. Luzuriaga K, Sullivan JL. 2010. Infectious mononucleosis. N Engl J Med. 362;7: 1993-2000. http://dx.doi.org/10.1056/NEJMcp1001116; PMid:20505178

11. Odumade OA. 2011. Progress and problems in understanding and managing primary Epstein—Barr virus infections. Clin Microbiology review. 24(1): 193—209. http://dx.doi.org/10.1128/CMR.00044-10; PMid:21233512 PMCid:PMC3021204

12. Paschale M, Clerici P. 2012. Serological diagnosis of Epstein—Barr virus infection: Problems and solutions. World J Virol. 1(1): 31—43. http://dx.doi.org/10.5501/wjv.v1.i1.31; PMid:24175209 PMCid:PMC3782265

13. Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. 2011. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 127: 1329—41. http://dx.doi.org/10.1016/j.jaci.2011.02.047; PMid:21514636

14. Kimura H, Morishima T, Kanegane H et al. 2003. Prognostic factors for chronic active Epstein—Barr Virus infection. The Journal of Infectious Diseases. 187: 527—33. http://dx.doi.org/10.1086/367988; PMid:12599068

15. Sumaya CV. 2009. Epstein—Barr virus. Textbook of Pediatric Infectious Diseases. RD Feigin, JD Cherry. 4th Ed. Philadelphia, W.B. Saunders: 1751—1762.

16. Valachis A, Kofteridis DP. 2012. Mononucleosis and Epstein—Barr virus infection: treatment and medication. Virus Adaptation and Treatment. 4: 23—28.

17. Williams H, Crawford DH. 2006. Epstein—Barr virus: the impact of scientific advances on clinical practice. Blood. 107: 862—869. http://dx.doi.org/10.1182/blood-2005-07-2702; PMid:16234359